Welcome to LookChem.com Sign In|Join Free
  • or
2,3'-Imino-dibenzoic acid, also known as DB 1, is a chemical compound with the molecular formula C13H9NO2. It is characterized by its yellow-green fluorescence when bound to DNA, making it a valuable fluorescent probe in biochemical and molecular biology research. Its ability to bind with DNA and emit fluorescence allows for the detection and visualization of nucleic acids in biological samples, contributing to its utility in various scientific applications.

27693-67-0

Post Buying Request

27693-67-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27693-67-0 Usage

Uses

Used in Biochemical and Molecular Biology Research:
2,3'-Imino-dibenzoic acid is used as a fluorescent probe for detecting and visualizing nucleic acids in biological samples. Its fluorescence properties upon binding to DNA make it a useful tool for studying the interactions between DNA and various ligands, as well as for investigating the structural and conformational changes in nucleic acids.
Used in Coordination Chemistry and Catalysis:
2,3'-Imino-dibenzoic acid is also used as a ligand in coordination chemistry and catalysis. Its versatility and potential applications in these scientific fields highlight its importance in advancing research and development in these areas.

Check Digit Verification of cas no

The CAS Registry Mumber 27693-67-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,6,9 and 3 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 27693-67:
(7*2)+(6*7)+(5*6)+(4*9)+(3*3)+(2*6)+(1*7)=150
150 % 10 = 0
So 27693-67-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H11NO4/c16-13(17)9-4-3-5-10(8-9)15-12-7-2-1-6-11(12)14(18)19/h1-8,15H,(H,16,17)(H,18,19)

27693-67-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(3-carboxyanilino)benzoic acid

1.2 Other means of identification

Product number -
Other names 2,3'-Imino-di-benzoesaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27693-67-0 SDS

27693-67-0Relevant academic research and scientific papers

Photochemical transformation of flufenamic acid by artificial sunlight in aqueous solutions

Rafqah, Salah,Sarakha, Mohamed

, p. 1 - 6 (2016)

In the present article, we have studied the photochemical behavior of a common non-steroidal anti-inflammatory drug (NSAIDs) namely flufenamic acid (FLUA) in aqueous solution. The absorption spectrum of such compound shows a significant absorption beyond

Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17β-hydroxysteroid dehydrogenase) based on N -phenyl-aminobenzoates and their structure-activity relationships

Adeniji, Adegoke O.,Twenter, Barry M.,Byrns, Michael C.,Jin, Yi,Chen, Mo,Winkler, Jeffrey D.,Penning, Trevor M.

, p. 2311 - 2323 (2012/05/04)

Aldo-keto reductase 1C3 (AKR1C3; type 5 17β-hydroxysteroid dehydrogenase) is overexpressed in castration resistant prostate cancer (CRPC) and is implicated in the intratumoral biosynthesis of testosterone and 5α-dihydrotestosterone. Selective AKR1C3 inhibitors are required because compounds should not inhibit the highly related AKR1C1 and AKR1C2 isoforms which are involved in the inactivation of 5α-dihydrotestosterone. NSAIDs, N-phenylanthranilates in particular, are potent but nonselective AKR1C3 inhibitors. Using flufenamic acid, 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid, as lead compound, five classes of structural analogues were synthesized and evaluated for AKR1C3 inhibitory potency and selectivity. Structure-activity relationship (SAR) studies revealed that a meta-carboxylic acid group relative to the amine conferred pronounced AKR1C3 selectivity without loss of potency, while electron withdrawing groups on the phenylamino B-ring were optimal for AKR1C3 inhibition. Lead compounds did not inhibit COX-1 or COX-2 but blocked the AKR1C3 mediated production of testosterone in LNCaP-AKR1C3 cells. These compounds offer promising leads toward new therapeutics for CRPC.

2,7-Dihydro-3H-pyridazino[5,4,3-kl]acridin-3-one derivatives, novel type of cytotoxic agents active on multidrug-resistant cell lines. Synthesis and biological evaluation

Stefanska, Barbara,Bontemps-Gracz, Maria M.,Antonini, Ippolito,Martelli, Sante,Arciemiuk, Malgorzata,Piwkowska, Agnieszka,Rogacka, Dorota,Borowski, Edward

, p. 1969 - 1975 (2007/10/03)

We have earlier postulated that the presence of a pyridazone ring fused with an anthracenedione moiety resulted in the analog's ability to overcome multidrug resistance of tumor cells [J. Med. Chem. 1999, 42, 3494]. High cytotoxic activity of obtained ant

Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors

Oza, Vibha B.,Petrassi, H. Michael,Purkey, Hans E.,Kelly, Jeffery W.

, p. 1 - 6 (2007/10/03)

Eight small molecules were synthesized to evaluate the structure activity relationships (SAR) of N-substituted anthranilic acids. The molecules were synthesized by benzylation or arylation of methyl anthranilate. A light scattering-based amyloid fibril formation assay was used to evaluate potential inhibitors of transthyretin (TTR) amyloid fibril formation in vitro. The m-carboxyphenylated and o-trifluoromethylphenylated anthranilic acids are potent inhibitors that will be subjected to further SAR and structural analysis.

Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesterase

Lowe III,Archer,Chapin,Cheng,Helweg,Johnson,Koe,Lebel,Moore,Nielsen,Russo,Shirley

, p. 624 - 628 (2007/10/02)

A series of quinazolinediones and azaquinazolinediones is described which possess potent inhibitory activity toward the calcium-independent phosphodiesterase enzyme (CaIPDE). In vivo testing showed that this in vitro activity translates to animal models p

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 27693-67-0